Makale detayı · 2021 · article
C-reactive protein and neutrophil–lymphocyte ratio as predictors of mortality in coronavirus disease 2019
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıRevista da Associação Médica Brasileira
- Katalog eşleşmesi (ISSN)Revista da Associacao Medica Brasileira
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
OBJECTIVE: This study investigates whether C-reactive protein, platelet-lymphocyte ratio, and neutrophil-lymphocyte ratio could be useful to predict mortality in COVID-19. METHODS: Data of 635 patients with COVID-19 followed up in Sinop Ataturk State Hospital from February to May 2020 were evaluated retrospectively. Diagnosis of COVID-19 was made according to the interim guidance of the World Health Organization. Patients were grouped into two groups based on mortality as survived and non-survived patients. Age, gender, neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein of the groups were investigated and compared. RESULTS: The mean age of the participants was 55.8±22.3 years. Among the patients, 584 survived and 51 patients died. Age was significantly different between the groups, 54.2±22.3 in the survived group and 75.6±11.1 in the dead group (p=0.000). In addition, neutrophil, C-reactive protein, and neutrophil-lymphocyte ratio values were significantly higher in the dead group (p=0.000). platelet-lymphocyte ratio was slightly higher in the dead group, but this difference was not significant (p=0.42). The area under the curve values for age, lymphocyte, platelet, C-reactive protein, and neutrophil-lymphocyte ratio are 0.797, 0.424, 0.485, 0.778, and 0.729, respectively. CONCLUSIONS: Our results showed that neutrophil-lymphocyte ratio and C-reactive protein are significantly higher in patients leading to death and could be effective biomarkers in predicting COVID-19 fatality. Furthermore, C-reactive protein could be used as an independent biomarker to predict death in patients with COVID-19, regardless of gender and age (p=0.000).
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
14atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 12 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2022 Multi-inflammatory Index as a Novel Mortality Predictor in Critically Ill COVID-19 PatientsAtıf 25 · OpenAlex
- 2022 Multi-inflammatory Index as a Novel Mortality Predictor in Critically Ill COVID-19 PatientsAtıf 25 · OpenAlex
- 2022 Multi-inflammatory Index as a Novel Mortality Predictor in Critically Ill COVID-19 PatientsAtıf 25 · OpenAlex
- 2022 Multi-inflammatory Index as a Novel Mortality Predictor in Critically Ill COVID-19 PatientsAtıf 25 · OpenAlex
- 2024 Neutrophil-to-lymphocyte ratio and red blood cell distribution width to platelet ratio and their relationships with inflammatory and antioxidant status in dogs with different stages of heart failure due to myxomatous mitral valve diseaseAtıf 8 · OpenAlex
- 2024 Neutrophil-to-lymphocyte ratio and red blood cell distribution width to platelet ratio and their relationships with inflammatory and antioxidant status in dogs with different stages of heart failure due to myxomatous mitral valve diseaseAtıf 8 · OpenAlex
- 2023 Can mean platelet volume be a prognosis predictor in viral infections: An example of Covid-19Atıf 7 · OpenAlex
- 2023 Can mean platelet volume be a prognosis predictor in viral infections: An example of Covid-19Atıf 7 · OpenAlex
- 2023 Can mean platelet volume be a prognosis predictor in viral infections: An example of Covid-19Atıf 7 · OpenAlex
- 2023 Can mean platelet volume be a prognosis predictor in viral infections: An example of Covid-19Atıf 7 · OpenAlex